Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Mitochondrial
Research dose range
Standard research range
10 - 20 mg
Fully interpolated — sits between the two studied doses with no independent source at this range.
Research focus
Mitochondrial function support
Observed window
4-24 weeks
Administration
Once daily
Primary pathway
Cardiolipin / ANT / ATP synthase
Reference data compiled from published Phase 2/3 clinical trials (MMPOWER, ReCLAIM, HFrEF studies) evaluating subcutaneous elamipretide administration. For research use only.
PROTOCOL BENEFITS
◆
Goes straight to the mitochondria — concentrating up to 5,000-fold at the inner membrane, the exact site where your cells convert fuel into usable energy.
◆
Targets cardiolipin, the structural molecule your mitochondria's membrane depends on to keep energy production running — not generic free-radical mopping.
◆
Studied across some of the toughest recovery challenges in biology — cardiac stress, muscle injury, and oxygen-deprived tissue.
SCIENCE
SS-31 is built to go where most compounds can't — through the mitochondrial membrane and into the exact zone where your cells convert fuel into usable energy. Its aromatic-cationic structure lets it cross the membrane without needing an energy gradient, concentrating up to 5,000-fold at the target site.
The early story was simple: SS-31 mops up free radicals. The newer story is more precise — it binds directly to ANT and ATP synthase, the machinery mitochondria use to actually produce ATP, improving how efficiently stressed or aging mitochondria convert fuel into energy.
WHAT TO EXPECT
Shorter research windows track measurable changes within 4 weeks. Functional outcomes — like walking distance and fatigue — are assessed over longer 24-week protocols.
PROTOCOL NOTE
Available in 10mg. For research use only. Full documentation included with every order.
FAQ
Most antioxidants scavenge free radicals wherever they land. SS-31 is built to concentrate specifically at the mitochondrial membrane — the actual site of cellular energy production.
Early markers can shift within 4 weeks. Functional outcomes are typically tracked over a longer 24-week window.
